Show simple item record

dc.creatorPapagiannis D., Laios T., Tryposkiadis K., Kouriotis K., Roussis X., Basdekis G., Boudouris P., Cholevas C., Karakitsios S., Kakavas P., Kiriakidis T., Kouloumentas P., Kouvidis G., Manoudis G., Nikolaou P., Theos C., Piskopakis A.-N., Rallis I., Ristanis S., Toliopoulos A., Zisis G., Theodorakis Y., Gourgoulianis K.I., Rachiotis G.en
dc.date.accessioned2023-01-31T09:43:13Z
dc.date.available2023-01-31T09:43:13Z
dc.date.issued2022
dc.identifier10.3390/vaccines10050634
dc.identifier.issn2076393X
dc.identifier.urihttp://hdl.handle.net/11615/77693
dc.description.abstractLittle is known about the risk of COVID-19 infection among footballers. We aimed to investigate the incidence and characteristics of COVID-19 infection among footballers. In total, 480 football players of Super League Greece and 420 staff members participated in a prospective cohort study, which took place from May 2020 to May 2021. Nasopharyngeal swabs were collected from footballers and staff members weekly. All samples (n = 43,975) collected were tested using the reverse transcriptase polymerase chain reaction (RT-PCR) test for the detection of “SARS-CoV-2”. In total, 190 positive cases (130 among professional football players and 60 among staff) were recorded. Out of the 190 cases that turned positive, 64 (34%) cases were considered as symptomatic, and 126 (66%) cases were asymptomatic. The incidence rate of a positive test result for footballers was 0.57% (confidence interval (CI) 0.48–0.68%) and for staff members it was 0.27% (CI 0.20%, 0.34%), respectively. Footballers recorded a twofold increased risk of COVID-19 infection in comparison to staff members (relative risk = 2.16; 95% CI = 1.59–2.93; p-value < 0.001). No significant transmission events were observed during the follow-up period. We found a low incidence of COVID-19 infection among professional footballers over a long follow-up period. Furthermore, the implementation of a weekly diagnostic testing (RT-PCR) was critical to break the transmission chain of COVID-19, especially among asymptomatic football players and staff members. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.en
dc.language.isoenen
dc.sourceVaccinesen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85129128310&doi=10.3390%2fvaccines10050634&partnerID=40&md5=106e115b64f981a32edb64615a00781c
dc.subjectinterferonen
dc.subjectadulten
dc.subjectArticleen
dc.subjectathleteen
dc.subjectcohort analysisen
dc.subjectcontrolled studyen
dc.subjectcoronavirus disease 2019en
dc.subjectfemaleen
dc.subjectfollow upen
dc.subjectfootball playeren
dc.subjecthumanen
dc.subjectmajor clinical studyen
dc.subjectmaleen
dc.subjectmulticenter studyen
dc.subjectnasopharyngeal swaben
dc.subjectnonhumanen
dc.subjectprospective studyen
dc.subjectreverse transcription polymerase chain reactionen
dc.subjectrisk factoren
dc.subjectSevere acute respiratory syndrome coronavirus 2en
dc.subjectvirus loaden
dc.subjectMDPIen
dc.titleCOVID-19 Infection among Elite Football Players: A Nationwide Prospective Cohort Studyen
dc.typejournalArticleen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record